Peptidoglycans promotes human leukemic THP-1 cell apoptosis and differentiation

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 12, 2012, Pages 6409-6413

  Wang, Di ^a   Xiao, Pei Ling ^a   Duan, Hua Xin ^a   Zhou, Ming ^a   Liu, Jin ^a   Li, Wei ^a   Luo, Ke Lin ^a   Chen, Jian Jun ^a   Hu, Jin Yue ^b  

^a Hunan Provincial Second People s Hospital   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Apoptosis; Differentiation; Leukemia cell line; PGN; TLR2

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 8; PEPTIDOGLYCAN; TLR2 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; DRUG EFFECT; HUMAN; LEUKEMIA; METABOLISM; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

APOPTOSIS; CELL DIFFERENTIATION; CELL LINE, TUMOR; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-8; LEUKEMIA; PEPTIDOGLYCAN; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84877067399     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.12.6409     Document Type: Article

References (22)

1. Aderem, A (2001). Role of Toll-like receptors in inflammatory response in macrophages. Crit Care Med, 29, S16-8.
2. Baldridge JR, McGowan P, Evans JT, et al (2004). Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents. Expert Opin Biol Ther, 4, 1129-38.
3. Blander JM, Medzhitov R (2006). Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature, 440, 808-12.
4. Bsibsi M, Nomden A, van Noort JM, et al (2012). Toll-like receptor 2 and 3 agonists differentially affect ologodendrocyte survival, differentiation, and myelin membrane formation. J Neurosci Res, 90, 388-98.
5. Bunting RA, Duffy KE, Lamb RJ, et al (2011). Novel antagonist antibody to TLR3 blocks poly(I:C)-induced inflammation in vivo and in vitro. Cell Immunol, 267, 9-16.
6. El Andaloussi A, Sonabend AM, Han Y, et al (2006). Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors. Glia, 54, 526-35.
7. Hermans IF, Silk JD, Gileadi U, et al (2007). Dendritic cell function can be modulated through cooperative action of TLR ligands and invariant NKT cells. J Immunol, 178, 2721-29.
8. Jahrsdorfer B, Wooldridge JE, Blackwell SE, et al (2005). B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides. Clin Cancer Res, 11, 1490-99.
9. Li N, Quidgley Mc, Kobeissy FH, et al (2012). Microbial cell components induced tolerance to flagellin-stimulated inflammation through Toll-like receptor pathways in in testinal epithelial cells. Cytokine, 60, 806-11.
10. Negishi H, Yanai H, Nakajima A, (2012). Cross-interference of RLR and TLR signaling pathways modulates antibacterial T cell responses. Nat Immunol, 13, 659-66.
11. Paone A, Starace D, Galli R, et al (2008). Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-alpha-dependent mechanism. Carcinogenesis, 29, 1334-42.
12. Peng G, Guo Z, Kiniwa Y, et al (2005). Toll-like receptor 8 mediated-reversal of CD4+ regulatory T cell function. Science, 309, 1380-84.
13. Rakhesh M, Cate M, Vijay R, et al (2012). A TLR4-interacting peptide inhibits lipopolysaccharide-stimulated inflammatory response, migration and invasion of colon cacer SW480. Oncoimmunology, 1, 1495-506.
14. Roses RE, Xu M, Koshi GK, et al (2008). Radiation therapy and Toll-like receptor signaling: implication for treatment of cancer. Oncegene, 27, 200-7.
15. Salaun B, Coste I, Rissoan MC, et al(2006). TLR3 can directly trigger apoptosis in human cancer cells. J Immunol, 176, 4894-901.
16. Stockfleth E, Trefzer U, Garcia-Bartels C, et al (2003). The use of Toll-like receptor-7 agonist in the treatment of basal cell carcinoma: an overview. Br J Dermatol, 149, 53-6.
17. Tabiasco J, Devevre E, Rufer N, et al (2006). Human effector CD8+ T lyphocytes express TLR3 as a functional coreceptor. J Immunol, 177, 8708-13.
18. Takaoka A, Yanai H, Kondo S, et al (2005). Integral role of IRF-5 in the gene induction programme activated by Toll-like recpors. Nature, 434, 243-49.
19. Wang ZD, Qiao YL, Tian XF, et al (2012). Toll-like receptor 5 agonism protects mice from radiation pneumotis and pulmonary fibrosis. Asian Pac J Cancer Prev, 13, 4763-7.
20. Wille-Reece U, Flynn BJ, Lore K, et al (2005). HIV Gap protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates. Proc Natl Acad Sci USA, 102, 15190-94.
21. Zoglmeier C, Bauer S, Norenberg D, CJ, et al (2011). CpG blocks immunosuppression by myeloid-derived suppressor cells in tumor-bearing mice. Clin Cancer Res, 17, 1765-75.
22. Zughaier SM (2011). Neisseria meningitides capsular polysaccharides induces inflammatory responses via TLR2 and TLR4-MD-2. J Leukoc Biol, 89, 469-80.